Poster about Factors related to cognitive impairment in fibromyalgia, neuropathic and musculoskeletal pain patients. 16th World Congress on Pain - IASP
Beliefs, opinions, and attitudes towards the use of opioids. A nationwide stu...Observatoriodolor
Poster about Beliefs, opinions, and attitudes towards the use of opioids. A nationwide study in the Spanish general population.16th World Congress on Pain - IASP
The Regulation and Development Act, 2016 & the Construction and Demolition Waste Management Rules, 2016 and its implications on Builders, Real Estate Agents, Developers, Ends Users etc.
Presentation by Professor Simon Haslett at the University of Wales, Newport, Centre for Excellence in Learning and Teaching (CELT) Writing Retreat Workshop at Gregynog Hall, Wales, on Wedmesday 11th May 2011. Simon Haslett is Professor of Physical Geography and Dean of the School of STEM at the University of Wales. He is also Visiting Professor of Pedagogic Research at the University of Wales, Newport.
Beliefs, opinions, and attitudes towards the use of opioids. A nationwide stu...Observatoriodolor
Poster about Beliefs, opinions, and attitudes towards the use of opioids. A nationwide study in the Spanish general population.16th World Congress on Pain - IASP
The Regulation and Development Act, 2016 & the Construction and Demolition Waste Management Rules, 2016 and its implications on Builders, Real Estate Agents, Developers, Ends Users etc.
Presentation by Professor Simon Haslett at the University of Wales, Newport, Centre for Excellence in Learning and Teaching (CELT) Writing Retreat Workshop at Gregynog Hall, Wales, on Wedmesday 11th May 2011. Simon Haslett is Professor of Physical Geography and Dean of the School of STEM at the University of Wales. He is also Visiting Professor of Pedagogic Research at the University of Wales, Newport.
Cognitive Impairment and Associated Factors in Patients with Chronic Pain. Pr...Observatoriodolor
Publicación: Abstract online. Accesible: http://www.abstracts2view.com/iasp/index.php
Conoce al Observatorio del Dolor: http://observatoriodeldolor.com/
Síguenos en Twitter: https://twitter.com/observadolor
A great presentation by Nathaniel Katz, MD, MS (CEO and owner, Analgesic Solutions) to the FDA in 2011 on sources of measurement error in pain clinical trials.
Ponencia invitada en la V Jornada de Fisioterapia en Geriatría, Barcelona 2015.
"Pain management in the elderly". Invited speaker at V Jornada de Fisioterapia en Geriatría, Barcelona 2015.
Austin Journal of Sleep Disorders is an open access, peer review Journal publishing original research & review articles in all fields of sleep disorders. Austin Journal of Sleep Disorders provides a new platform for researchers, scientists, scholars and academicians to publish and find recent advances in treatment of sleep disorders.
Austin Journal of Sleep Disorders is a comprehensive Open Access peer reviewed scientific Journal that covers multidisciplinary fields. We provide limitless access towards accessing our literature hub with colossal range of articles. The journal aims to publish high quality varied article types such as Research, Review, Short Communications, Case Reports, Perspectives (Editorials), Clinical Images.
Austin Journal of Sleep Disorders supports the scientific modernization and enrichment of research community by magnifying access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Post-discharge issues beyond pain in out-patient surgeryscanFOAM
A presentation by Johan Ræder at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
Running head: NECK PAIN 1
NECK PAIN 2
NECK PAIN
Bamgbola Abitogun
Grand Canyon University
NRS 433V
April 2nd, 2017
Dosage impacts of spinal manipulative treatment for endless neck torment Comment by Denise Foti: APA: The first line of your paper needs to be your paper title not bold-faced
Neck pain is second most common spinal pain to low back torment among musculoskeletal grievances revealed in the all inclusive community and among those exhibiting to manual treatment suppliers. Ceaseless neck torment (i.e. neck torment enduring longer than 90 days) is a typical purpose behind introducing to a chiropractor's office, and such patients frequently get spinal control or activation. Comment by Denise Foti: Indent
Research question: In adults with chronic neck pain, what is the base measurements of control important to create a clinically vital change in neck pain contrasted with directed practice in 2 months Comment by Denise Foti: You need to revise this. Look at the example I provided the first day of class.
(P)-Population: Adults 18 to 60 years old, with a clinical conclusion of endless mechanical neck pain who have not gotten cervical spinal manipulative therapy in the previous year. Patients with non-mechanical neck agony or contraindications to cervical control will be rejected.
(I)-Intervention: Subjects randomized to have control would get standard rotational or sidelong break enhanced method once, twice, or three times each week over a time of 2, 4, or a month and a half. These subjects would likewise get a similar practice regimen given to the control gathering to take out practice as a moment variable influencing results.
(C)-Comparison-An institutionalized administered practice regimen would be utilized as a dynamic control bunch. All subjects, paying little heed to gathering task, would play out an institutionalized practice administration at every session over a time of a month and a half. Utilizing this methodology, we will have the capacity to limit the non-particular impacts because of going to a facility.
(O)-Outcome- Changes in neck pain, measured utilizing the 100mm VAS for agony.
(T)-Time-The result would be measured week by week for two months
Reference
Vernon, H., & Mior, S. (January 01, 1991). The Neck Disability Index: a study of reliability and validity. Journal of Manipulative and Physiological Therapeutics, 14, 7, 409-15.
Injuries to the cervical spine, particularly those including the delicate tissues, speak to a huge wellspring of unending handicap. Techniques for appraisal for such inability, particularly those focused at exercises of day by day living which are most influenced by neck agony, are very few. An alteration of the Oswestry Low Back Pain Index was led ...
An Internet questionnaire to predict the presence or absence of organic patho...Nelson Hendler
The Pain Validity Test, developed by a team of physicians from Johns Hopkins Hospital, is available over the Internet, at www.MarylandClinicalDiagnostics.com. The test can predict, with 95% accuracy, which patient will have abnormalities on medical tersting, i.e. who has a valid complaint of pain. The test takes only 5 minutes to set up a patient, 15 minutes for a patient to take the test, and results are available immediately after completion. The test has been admitted as evidence in court cases in over 30 cases in 8 states.
CARACTERIZACIÓN SENSORIAL DEL DOLOR CRÓNICO DE TIPO NEUROPÁTICO EN PACIENTES ...Observatoriodolor
Introducción:
El Síndrome de Dolor Regional Complejo (SDRC) es una enfermedad no muy bien definida que se asocia con la presencia de ansiedad o estados depresivos y trastornos cognitivos.
Objetivos:
Caracterizar sensorialmente el dolor en pacientes con SDRC y su relación con depresión y ansiedad. Comparar los resultados entre pacientes con SDRC y con síndrome ciático (SC).
Material y Método:
Estudio transversal en 32 pacientes con diagnóstico de SDRC o SC seguidos en las Unidades del Dolor de los Hospitales Universitarios Puerta del Mar y La Princesa. Se recogió información sociodemográfica y se administraron los cuestionarios DN4, SF-12, HADS y BPI. Se realizó un análisis descriptivo y de la asociación de ansiedad y/o depresión y las diferencias por grupo diagnóstico mediante pruebas chi-cuadrado y t-Student.
Resultados:
17 pacientes padecían SDRC y 15 SC. 59% y 53%, respectivamente, fueron mujeres. Los pacientes con SC fueron mayores (56.8 vs 39.5 años). La intensidad del dolor fue similar en ambos grupos (SDRC:7.69;SC:8;p=0.77). Todos los pacientes con SDRC tuvieron una puntuación en DN4 superior a 3, lo que los clasifica como pacientes con DN. La media en DN4 fue de 5.7 vs. 3.47 en el grupo de SC. Se observaron diferencias fenotípicas entre ambos grupos. Las puntuaciones en el Componente Físico (31 en SDRC vs. 28.1 en SC) y mental (39.2 vs. 44) de la calidad de vida fue baja y similar en ambos grupos. La frecuencia de ansiedad (47% en SDRC vs. 33% en SC) y depresión (35.3% vs 20%) fue mayor en pacientes con SDRC. Las medias en el HADS de ansiedad y depresión fueron mayores en los pacientes con mayor puntuación en la escala DN4.
Conclusiones:
Todos los pacientes con SDRC cumplían con los criterios de DN, con diferencias tanto en intensidad como en el fenotipo frente al grupo con SC. La ansiedad y la depresión fueron más frecuentes en pacientes con SDRC y en aquellos con un mayor perfil neuropático.
EFECTO DE LA FUNCIÓN COGNITIVA Y LAS ALTERACIONES DEL SUEÑO SOBRE LA PRESENCI...Observatoriodolor
Introducción:
Existe una relación bidireccional entre las Alteraciones del Sueño (AS) y el Dolor Crónico (DC), que se ve afectada por los trastornos del humor. El DC altera el procesamiento normal del sistema nervioso, pudiendo ocasionar déficits en la función cognitiva (FC). No está claro si todos estos aspectos podrían variar y asociarse de manera diferente según los distintos tipos de DC, como Dolor Neuropático (DNP), Musculoesquelético (DMSC) y Fibromialgia (FM).
Objetivos:
Analizar la FC, las AS y presencia de ansiedad y/o depresión (A/D) en pacientes con DNP, DMSC y FM, y compararla con un grupo de sujetos sin dolor. Conocer el efecto de la FC y las AS sobre la presencia de A/D en dichos pacientes.
Material y Método:
Se incluyeron 254 pacientes (18-60 años) que sufrían DC de al menos 3 meses de duración (criterio IASP), con diagnóstico confirmado de DNP o DMSC (criterios clínicos), o FM (criterio ACR). Se incluyó un grupo de 72 sujetos sin dolor (GSD), apareados por edad y sexo con los casos. Se evaluó la FC con las escalas MMSE y TYM, la presencia de A/D mediante escala HADS, las AS mediante el índice 9 de la escala MOS (I-9), e intensidad del dolor mediante EVA. Se llevaron a cabo análisis descriptivos y multivariantes (regresión logística) para analizar el efecto de la FC y las AS sobre la presencia de A/D en pacientes con DC.
Resultados:
40.9% de los pacientes tenían DNP, 39% DMSK y 20.1% FM. Los pacientes con DC obtuvieron peores puntuaciones que el GSD en las escalas de A/D, AS y FC. La presencia de depresión se asoció a mayor riesgo de ansiedad en DN (OR=1.247), DMSC (OR=1.308) y FB (OR=1.15). Peor FC se asoció a mayor riesgo de depresión en DNP (OR=0.879), DMSC (OR=0.838) y FB (OR=0.829). Peores puntuaciones I-9 se asociaron a mayor riesgo de depresión en FM (OR=1.054), y de ansiedad en DNP (OR=1.028) y DMSC (OR=1.035). La presencia de ansiedad se asoció a mayor riesgo de depresión en DNP (OR=1.23) y DMSC (OR=1.483).
Conclusiones:
La presencia de A/D, las AS y de la FC son más frecuentes en pacientes con DC, especialmente FM. Las AS y una peor FC son los factores con mayor impacto sobre la presencia de A/D en pacientes con DC, por encima de otras variables propias del dolor como la intensidad o duración. Estas relaciones son distintas dependiendo del tipo de dolor.
Palabras clave:
Ansiedad; Depresión; Sueño; Función cognitiva; Dolor crónico.
Agradecimientos:
A la Cátedra Externa del Dolor Fundación Grünenthal-Universidad de Cádiz. Los autores declaran que este trabajo no incurre en ningún conflicto de intereses.
More Related Content
Similar to Factors related to cognitive impairment in fibromyalgia, neuropathic and musculoskeletal pain patients.
Cognitive Impairment and Associated Factors in Patients with Chronic Pain. Pr...Observatoriodolor
Publicación: Abstract online. Accesible: http://www.abstracts2view.com/iasp/index.php
Conoce al Observatorio del Dolor: http://observatoriodeldolor.com/
Síguenos en Twitter: https://twitter.com/observadolor
A great presentation by Nathaniel Katz, MD, MS (CEO and owner, Analgesic Solutions) to the FDA in 2011 on sources of measurement error in pain clinical trials.
Ponencia invitada en la V Jornada de Fisioterapia en Geriatría, Barcelona 2015.
"Pain management in the elderly". Invited speaker at V Jornada de Fisioterapia en Geriatría, Barcelona 2015.
Austin Journal of Sleep Disorders is an open access, peer review Journal publishing original research & review articles in all fields of sleep disorders. Austin Journal of Sleep Disorders provides a new platform for researchers, scientists, scholars and academicians to publish and find recent advances in treatment of sleep disorders.
Austin Journal of Sleep Disorders is a comprehensive Open Access peer reviewed scientific Journal that covers multidisciplinary fields. We provide limitless access towards accessing our literature hub with colossal range of articles. The journal aims to publish high quality varied article types such as Research, Review, Short Communications, Case Reports, Perspectives (Editorials), Clinical Images.
Austin Journal of Sleep Disorders supports the scientific modernization and enrichment of research community by magnifying access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed member journals under one roof thereby promoting knowledge sharing, collaborative and promotion of multidisciplinary science.
Post-discharge issues beyond pain in out-patient surgeryscanFOAM
A presentation by Johan Ræder at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
Running head: NECK PAIN 1
NECK PAIN 2
NECK PAIN
Bamgbola Abitogun
Grand Canyon University
NRS 433V
April 2nd, 2017
Dosage impacts of spinal manipulative treatment for endless neck torment Comment by Denise Foti: APA: The first line of your paper needs to be your paper title not bold-faced
Neck pain is second most common spinal pain to low back torment among musculoskeletal grievances revealed in the all inclusive community and among those exhibiting to manual treatment suppliers. Ceaseless neck torment (i.e. neck torment enduring longer than 90 days) is a typical purpose behind introducing to a chiropractor's office, and such patients frequently get spinal control or activation. Comment by Denise Foti: Indent
Research question: In adults with chronic neck pain, what is the base measurements of control important to create a clinically vital change in neck pain contrasted with directed practice in 2 months Comment by Denise Foti: You need to revise this. Look at the example I provided the first day of class.
(P)-Population: Adults 18 to 60 years old, with a clinical conclusion of endless mechanical neck pain who have not gotten cervical spinal manipulative therapy in the previous year. Patients with non-mechanical neck agony or contraindications to cervical control will be rejected.
(I)-Intervention: Subjects randomized to have control would get standard rotational or sidelong break enhanced method once, twice, or three times each week over a time of 2, 4, or a month and a half. These subjects would likewise get a similar practice regimen given to the control gathering to take out practice as a moment variable influencing results.
(C)-Comparison-An institutionalized administered practice regimen would be utilized as a dynamic control bunch. All subjects, paying little heed to gathering task, would play out an institutionalized practice administration at every session over a time of a month and a half. Utilizing this methodology, we will have the capacity to limit the non-particular impacts because of going to a facility.
(O)-Outcome- Changes in neck pain, measured utilizing the 100mm VAS for agony.
(T)-Time-The result would be measured week by week for two months
Reference
Vernon, H., & Mior, S. (January 01, 1991). The Neck Disability Index: a study of reliability and validity. Journal of Manipulative and Physiological Therapeutics, 14, 7, 409-15.
Injuries to the cervical spine, particularly those including the delicate tissues, speak to a huge wellspring of unending handicap. Techniques for appraisal for such inability, particularly those focused at exercises of day by day living which are most influenced by neck agony, are very few. An alteration of the Oswestry Low Back Pain Index was led ...
An Internet questionnaire to predict the presence or absence of organic patho...Nelson Hendler
The Pain Validity Test, developed by a team of physicians from Johns Hopkins Hospital, is available over the Internet, at www.MarylandClinicalDiagnostics.com. The test can predict, with 95% accuracy, which patient will have abnormalities on medical tersting, i.e. who has a valid complaint of pain. The test takes only 5 minutes to set up a patient, 15 minutes for a patient to take the test, and results are available immediately after completion. The test has been admitted as evidence in court cases in over 30 cases in 8 states.
Similar to Factors related to cognitive impairment in fibromyalgia, neuropathic and musculoskeletal pain patients. (20)
CARACTERIZACIÓN SENSORIAL DEL DOLOR CRÓNICO DE TIPO NEUROPÁTICO EN PACIENTES ...Observatoriodolor
Introducción:
El Síndrome de Dolor Regional Complejo (SDRC) es una enfermedad no muy bien definida que se asocia con la presencia de ansiedad o estados depresivos y trastornos cognitivos.
Objetivos:
Caracterizar sensorialmente el dolor en pacientes con SDRC y su relación con depresión y ansiedad. Comparar los resultados entre pacientes con SDRC y con síndrome ciático (SC).
Material y Método:
Estudio transversal en 32 pacientes con diagnóstico de SDRC o SC seguidos en las Unidades del Dolor de los Hospitales Universitarios Puerta del Mar y La Princesa. Se recogió información sociodemográfica y se administraron los cuestionarios DN4, SF-12, HADS y BPI. Se realizó un análisis descriptivo y de la asociación de ansiedad y/o depresión y las diferencias por grupo diagnóstico mediante pruebas chi-cuadrado y t-Student.
Resultados:
17 pacientes padecían SDRC y 15 SC. 59% y 53%, respectivamente, fueron mujeres. Los pacientes con SC fueron mayores (56.8 vs 39.5 años). La intensidad del dolor fue similar en ambos grupos (SDRC:7.69;SC:8;p=0.77). Todos los pacientes con SDRC tuvieron una puntuación en DN4 superior a 3, lo que los clasifica como pacientes con DN. La media en DN4 fue de 5.7 vs. 3.47 en el grupo de SC. Se observaron diferencias fenotípicas entre ambos grupos. Las puntuaciones en el Componente Físico (31 en SDRC vs. 28.1 en SC) y mental (39.2 vs. 44) de la calidad de vida fue baja y similar en ambos grupos. La frecuencia de ansiedad (47% en SDRC vs. 33% en SC) y depresión (35.3% vs 20%) fue mayor en pacientes con SDRC. Las medias en el HADS de ansiedad y depresión fueron mayores en los pacientes con mayor puntuación en la escala DN4.
Conclusiones:
Todos los pacientes con SDRC cumplían con los criterios de DN, con diferencias tanto en intensidad como en el fenotipo frente al grupo con SC. La ansiedad y la depresión fueron más frecuentes en pacientes con SDRC y en aquellos con un mayor perfil neuropático.
EFECTO DE LA FUNCIÓN COGNITIVA Y LAS ALTERACIONES DEL SUEÑO SOBRE LA PRESENCI...Observatoriodolor
Introducción:
Existe una relación bidireccional entre las Alteraciones del Sueño (AS) y el Dolor Crónico (DC), que se ve afectada por los trastornos del humor. El DC altera el procesamiento normal del sistema nervioso, pudiendo ocasionar déficits en la función cognitiva (FC). No está claro si todos estos aspectos podrían variar y asociarse de manera diferente según los distintos tipos de DC, como Dolor Neuropático (DNP), Musculoesquelético (DMSC) y Fibromialgia (FM).
Objetivos:
Analizar la FC, las AS y presencia de ansiedad y/o depresión (A/D) en pacientes con DNP, DMSC y FM, y compararla con un grupo de sujetos sin dolor. Conocer el efecto de la FC y las AS sobre la presencia de A/D en dichos pacientes.
Material y Método:
Se incluyeron 254 pacientes (18-60 años) que sufrían DC de al menos 3 meses de duración (criterio IASP), con diagnóstico confirmado de DNP o DMSC (criterios clínicos), o FM (criterio ACR). Se incluyó un grupo de 72 sujetos sin dolor (GSD), apareados por edad y sexo con los casos. Se evaluó la FC con las escalas MMSE y TYM, la presencia de A/D mediante escala HADS, las AS mediante el índice 9 de la escala MOS (I-9), e intensidad del dolor mediante EVA. Se llevaron a cabo análisis descriptivos y multivariantes (regresión logística) para analizar el efecto de la FC y las AS sobre la presencia de A/D en pacientes con DC.
Resultados:
40.9% de los pacientes tenían DNP, 39% DMSK y 20.1% FM. Los pacientes con DC obtuvieron peores puntuaciones que el GSD en las escalas de A/D, AS y FC. La presencia de depresión se asoció a mayor riesgo de ansiedad en DN (OR=1.247), DMSC (OR=1.308) y FB (OR=1.15). Peor FC se asoció a mayor riesgo de depresión en DNP (OR=0.879), DMSC (OR=0.838) y FB (OR=0.829). Peores puntuaciones I-9 se asociaron a mayor riesgo de depresión en FM (OR=1.054), y de ansiedad en DNP (OR=1.028) y DMSC (OR=1.035). La presencia de ansiedad se asoció a mayor riesgo de depresión en DNP (OR=1.23) y DMSC (OR=1.483).
Conclusiones:
La presencia de A/D, las AS y de la FC son más frecuentes en pacientes con DC, especialmente FM. Las AS y una peor FC son los factores con mayor impacto sobre la presencia de A/D en pacientes con DC, por encima de otras variables propias del dolor como la intensidad o duración. Estas relaciones son distintas dependiendo del tipo de dolor.
Palabras clave:
Ansiedad; Depresión; Sueño; Función cognitiva; Dolor crónico.
Agradecimientos:
A la Cátedra Externa del Dolor Fundación Grünenthal-Universidad de Cádiz. Los autores declaran que este trabajo no incurre en ningún conflicto de intereses.
Percepción y actitud de los médicos rehabilitadores españoles hacia el pacien...Observatoriodolor
Poster sobre la percepción y actitud de los médicos rehabilitadores españoles hacia el paciente con Dolor
Crónico para el XXV Congreso de la Asociación Andaluza del Dolor
Factores relacionados con la calidad de vida en pacientes con dolor crónico. ...Observatoriodolor
Poster sobre los Factores relacionados con la calidad de vida en pacientes con dolor crónico. diferencias entre pacientes con dolor neuropático, musculoesquelético y fibromialgia. Para la XXXIV Reunión Científica de la SEE. XI Congresso de Associação Portuguesa de Epidemiologia
Impacto de los síntomas somáticos y dolor medidos mediante la escala SSI-28 (...Observatoriodolor
Impacto de los síntomas somáticos y dolor medidos mediante la escala SSI-28 (Somatic Symptom Inventory) en la Calidad de Vida Relacionada con la Salud en pacientes con depresión.
Creencias, opiniones y actitudes de la población general hacia el uso de opiá...Observatoriodolor
Creencias, opiniones y actitudes de la población general hacia el uso de opiáceos en el tratamiento del dolor: Resultados preliminares de una encuesta nacional.
Infografía realizada por el Observatorio del Dolor.
Conoce al Observatorio del Dolor: http://observatoriodeldolor.com/
Síguenos en Twitter: https://twitter.com/observadolor
Test Your Memory (TYM): a new tool to evaluate the cognitive function in chro...Observatoriodolor
Publicación: Abstract Book of the 15th World Congress on Pain; 2014.p.62.
Conoce al Observatorio del Dolor: http://observatoriodeldolor.com/
Síguenos en Twitter: https://twitter.com/observadolor
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Factors related to cognitive impairment in fibromyalgia, neuropathic and musculoskeletal pain patients.
1. Factors related to cognitive impairment in fibromyalgia, neuropathic and musculoskeletal pain patients.
B Ojedaa
, M Dueñasb
, A Salazara
, JA Micoc
, LM Torresd
, I Faildea
a
Preventive Medicine and Public Health Area, The Observatory of Pain (External Chair of Pain), University of Cádiz, Spain.
b
Salus Infirmorum Faculty of Nursing, University of Cádiz.
c
Department of Neuroscience, Pharmacology and Psychiatry, CIBER of Mental Health, CIBERSAM, Instituto de Salud Carlos III, University of Cádiz, Plaza Fragela 9, 11003 Cádiz, Spain.
d
Department of Anesthesiology-Critical Care and Pain Management, University Hospital “Puerta del Mar”, Avenue Ana de Viya 21, 11009 Cádiz, Spain.
To compare the cognitive function of patients diagnosed with
neuropathic pain (NP), musculoskeletal pain (MSK) and
fibromyalgia (FM), and to analyse the factors associates to
cognitive function in each group.
Cognitive performance (Test Your Memory scale: TYM).
Pain intensity (Visual Analogue Scale: VAS).
Anxiety and depression (Hospital Anxiety and Depression scale: HADs)
Sleep quality (MOS-sleep).
Results
Conclusion These results highlight the importance of assessing cognitive performance in CP patients depending on the type of pain and analysing the effect of the emotional state of the patient, especially if depression is present.
Acknowledgments: This work was supported by the External Chair of Pain, collabo-
ration between the University of Cádiz and the Grünenthal Foundation. The Grünen-
thal Foundation is a private non-profitable organization that promotes the dissemi-
nation of scientific knowledge and supports research.
Aim of Investigation
Methods
Poster Presentation Board Number: 39
Presentation Date: Friday, September 30 2016
Presentation Time: 3:15-4:15 PM
External Chair of Pain
Grünenthal Foundation -University of Cádiz
Follow on Twitter
@observadolor
Our web site:
https://observatoriodeldolor.com/
Observatory of Pain
A research group for the study of pain in our social environment
Avda. Ana de Viya, 52
11009 Cádiz (SPAIN)
Design
Subjects
254 chronic pain patients
72 controls (no pain)
104 neuropatic pain
99 musculoskeletal
51 fibromyalgia
Linear regression models to analyse the relationships between cognitive
performance and intensity and duration of pain, sleep quality and anxiety
and depression.
Cross-sectional study
Instruments
and variables
Statistical
analyses
Quadratic relationship between pain duration and
TYM score (NP: n=104).
Demographic and clinical characteristics of the sample.
Chronic Pain
Patients (254)
Controls (72) p Neuropathic
Pain (104)
Musculoskele-
tal Pain (99)
Fibromyalgia
(51)
p
Sex (%)
Men
Women
36.2
63.8
43.1
56.9
0.18 47.1
52.9
41.4
58.6
3.9
96.1
<0.001
Age Mean (SD) 47.42 (8.8) 40 (11.11) <0.001 45.59 (8.68) 47.63 (9.42) 50.76 (6.7) 0.002
Academic level
No education
1ary education
2ary/Vocational training
University studies
11.8
39
40.9
8.3
5.6
22.2
36.1
36.1
<0.001 10.6
47.1
37.5
4.8
14.1
34.3
40.4
11.1
9.8
31.4
49
9.8
0.27
Co-morbidity (% yes) 74.4 43.1 <0.001 73.1 67.7 90.2 0.010
Pharmacological drugs (% yes)
Antidepressant
BZD
Anticonvulsivants
Opioids
NSAID
83.9
32.2
42.1
45.7
53.9
8.3
20.8
5.6
8.3
1.4
0
2.8
<0.001
<0.001
<0.001
<0.001
<0.001
0.082
89.4
33.7
39.4
52.9
61.5
7.7
75.8
27.3
39.4
44.4
52.5
10.1
88.2
58.8
52.9
33.3
41.2
5.9
0.019
0.001
0.216
0.068
0.054
0.648
Intensity Mean (SD) 6.65 (1.87) - - 6.63 (1.85) 6.7 (2) 6.59 (1.67) 0.86
Duration Mean (SD) 108.5 (97.6) - - 92.11 (82.7) 102 (97.42) 154.53 (112.7) 0.001
HADs-A Mean (SD) 9.45 (4.93) 3.61 (4.05) <0.001 9.01 (4.84) 8.89 (5) 11.43 (4.57) 0.004
HADs-D Mean (SD) 7.88 (5.18) 2.06 (2.3) <0.001 7.92 (5.3) 7.35 (5.28) 8.82 (4.66) 0.15
Index 9 Mean (SD) 52.41 (21.68) 29.34 (13.21) <0.001 52.41 (21.78) 49.42 (22.4) 58.19 (19.1) 0.072
Optimal sleep (%) 19.7 52.8 <0.001 18.3 24.2 13.7 0.28
HADs-A: hospital and depression scale-Anxiety; HADs-D: hospital and depression scale-Depression; Optimal sleep: 6 to 8 hours sleep.
Fibrmyalgia
Variables B (SE) CI (95%) p
Academic level
1ary education
2ary/Vocational training
University studies
HADs_Depression
Intensity
Intensity*Depression
2.99(1.86)
5.85(1.79)
7.61(2.35)
-1.08(0.42)
-0.57(0.64)
-1.51(0.46)
(-0.77;6.75)
(2.24;9.46)
(2.87;12.35)
(-1.92;-0.23)
(-1.87;0.71)
(-2.44;-0.58)
0.12
0.002
0.002
0.014
0.37
0.026
n=49; R2
corrected = 0.36
All Chronic Pain Patients
Variables B (SE) CI (95%) p
Age
Academic level
1ary education
2ary/Vocational training
University studies
HADs_Depression
-0.082(0.03)
4.047(0.97)
6.702(0.97)
8.759(1.34)
-0.288(0.06)
(-0.15;-0.02)
(2.14;5.96)
(4.79;8.61)
(6.11;11.41)
(-0.4;-0.17)
0.014
<0.001
<0.001
<0.001
<0.001
N=254; R2
corrected: 0.32
Musculoskeletal Pain
Variables B (SE) CI (95%)
(Inf; Sup)
p
Age
Academic level
1ary education
2ary/Vocational training
University studies
HADs_Depression
-0.09(0.05)
3.04(1.35)
6.42(1.33)
6.89(1.75)
-0.37(0.08)
(-0.18;-0.00)
(0.37;5.72)
(3.78;9.06)
(3.41;10.36)
(-0.53;-0.2)
0.046
0.026
<0.001
<0.001
<0.001
n=99; R2
corrected = 0.41
Neuropathic Pain
Variables B (SE) CI (95%)
(Inf; Sup)
p
Age
Academic level
1ary education
2ary/Vocational training
University studies
HADs_Depression
Duration (quadratic)
Duration (lineal)
-0.12(0.06)
5.29(1.78)
7.67(1.84)
12.96(2.88)
-0.19(0.1)
1.4x10-4(7x10-5)
-0.03(0.02)
(-0.24; 0.01)
(1.77;8.82)
(4.01;11.32)
(7.25;18.67)
(-0.39;0.02)
(1x10-6;2.8x10-4)
(-0.06;0.01)
0.06
0.004
<0.001
<0.001
0.072
0.048
0.20
n=104; R2
corrected = 0.29
Global model
Models for each pain group